3 Year Absolute Returns
94.74% ↑
NAV (₹) on 16 Nov 2026
623.72
1 Day NAV Change
-0.69%
Risk Level
Very High Risk
Rating
-
SBI Healthcare Opportunities Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by SBI Funds Management Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP ... Read more
AUM
₹ 6,067.13 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 65.33% |
| Hospitals & Medical Services | 28.19% |
| Treps/Reverse Repo | 4.14% |
| Chemicals - Speciality | 2.00% |
| Medical Equipment & Accessories | 1.53% |
| Treasury Bill | 0.05% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.55% | ₹ 639.97 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 8.38% | ₹ 508.56 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 4.96% | ₹ 301.05 | Hospitals & Medical Services |
| Acutaas Chemicals Ltd. | 4.95% | ₹ 300.27 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 4.87% | ₹ 295.17 | Hospitals & Medical Services |
| Laurus Labs Ltd. | 4.76% | ₹ 288.66 | Pharmaceuticals |
| Cipla Ltd. | 4.36% | ₹ 264.75 | Pharmaceuticals |
| TREPS | 4.14% | ₹ 251.38 | Others |
| Torrent Pharmaceuticals Ltd. | 4.11% | ₹ 249.12 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 3.10% | ₹ 188.32 | Pharmaceuticals |
| Gland Pharma Ltd. | 3.06% | ₹ 185.75 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 3.03% | ₹ 183.91 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 2.57% | ₹ 155.81 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 2.57% | ₹ 155.75 | Pharmaceuticals |
| Paras Healthcare Ltd. | 2.49% | ₹ 151.30 | Hospitals & Medical Services |
| Corona Remedies Ltd. | 2.41% | ₹ 146.17 | Pharmaceuticals |
| Sudeep Pharma Ltd. | 2.39% | ₹ 145.29 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 2.28% | ₹ 138.27 | Hospitals & Medical Services |
| Biocon Ltd. | 2.17% | ₹ 131.93 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd. | 2.12% | ₹ 128.57 | Hospitals & Medical Services |
| Aether Industries Ltd. | 2.00% | ₹ 121.22 | Chemicals - Speciality |
| Concord Biotech Ltd. | 1.97% | ₹ 119.58 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 1.85% | ₹ 112.29 | Hospitals & Medical Services |
| Global Health Ltd. | 1.67% | ₹ 101.62 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 1.61% | ₹ 97.75 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 1.57% | ₹ 95.32 | Hospitals & Medical Services |
| Ajanta Pharma Ltd. | 1.56% | ₹ 94.74 | Pharmaceuticals |
| Polymedicure Ltd. | 1.53% | ₹ 92.77 | Medical Equipment & Accessories |
| Innova Captab Ltd. | 1.41% | ₹ 85.44 | Pharmaceuticals |
| Healthcare Global Enterprises Ltd. | 1.35% | ₹ 81.98 | Hospitals & Medical Services |
| Mankind Pharma Ltd. | 1.23% | ₹ 74.78 | Pharmaceuticals |
| Syngene International Ltd. | 1.19% | ₹ 72.49 | Pharmaceuticals |
| Nephrocare Health Services Ltd. | 1.01% | ₹ 61.45 | Hospitals & Medical Services |
| Manipal Health Enterprises Ltd | 0.99% | ₹ 60.22 | Hospitals & Medical Services |
| Zydus Lifesciences Ltd. | 0.47% | ₹ 28.58 | Pharmaceuticals |
| Gufic Biosciences Ltd. | 0.27% | ₹ 16.54 | Pharmaceuticals |
| Abbott India Ltd. | 0.21% | ₹ 12.82 | Pharmaceuticals |
| 364 DAY T-BILL 19.11.26 | 0.05% | ₹ 2.99 | Others |
| Novartis India Ltd. | 0.03% | ₹ 2.06 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 29.06% | 25.09% | 15.20% | 24.88% |
| Category returns | 7.34% | 5.08% | 9.77% | 22.47% |
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹23.46 | 30.32% | 124.36% | 0.00% | ₹3,666 | 1.03% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
SBI Gold ETF
ETF
Regular
|
₹113.93 | 6.82% | 114.84% | 157.83% | ₹25,710 | 0.65% |
High
|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹40.58 | 5.98% | 113.92% | 157.87% | ₹16,744 | 0.25% |
Very High
|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹40.52 | 5.98% | 113.92% | 157.86% | ₹16,744 | 0.25% |
Very High
|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹40.52 | 5.98% | 113.92% | 157.86% | ₹16,744 | 0.25% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹38.69 | 5.81% | 112.74% | 154.87% | ₹16,744 | 0.42% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹38.69 | 5.80% | 112.72% | 154.85% | ₹16,744 | 0.42% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹38.69 | 5.80% | 112.72% | 154.85% | ₹16,744 | 0.42% |
Very High
|
|
SBI Healthcare Opportunities Fund - Direct Plan
Sector
Direct
|
₹433.34 | 25.09% | 94.74% | 151.51% | ₹6,067 | 1.01% |
Very High
|
|
SBI Healthcare Opportunities Fund - Direct Plan
Sector
Direct
|
₹433.34 | 25.09% | 94.74% | 151.51% | ₹6,067 | 1.01% |
Very High
|
|
SBI Healthcare Opportunities Fund
Sector
Regular
|
₹338.59 | 23.84% | 88.82% | 138.70% | ₹6,067 | 1.99% |
Very High
|
What is the current NAV of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What is the fund size (AUM) of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What are the historical returns of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What is the risk level of SBI Healthcare Opportunities Fund - Direct Plan Growth?
What is the minimum investment amount for SBI Healthcare Opportunities Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article